Biomutant arrived earlier this year, and after years of hype, it didn't quite make the lasting impression many hoped it would. While by no means a terrible game, the general consensus placed it in a fairly average light, with it doing very little to differentiate itself from the crowd. That being said, the game has gone on to to be a success and is also claimed to have recouped all of its development costs within the first week of its launch.
Embracer Group, the company that owns publisher THQ Nordic, revealed the news during its interim Q1 2021 financial results. Along with selling over 1 million copies, Biomutant is said to have been the main revenue driver in the last quarter for the company.
"The main revenue driver in the quarter was the release of Biomutant from our internal studio Experiment 101. So far, the game has sold more than one million copies. The full investment into development and marketing as well as the acquisition cost for Experiment 101 and the IP, was recouped within a week after launch."
It's interesting that Biomutant's claimed success follows the news of Outriders seemingly suffering the opposite. Despite a huge Xbox Game Pass launch, the developers at People Can Fly are still yet to receive royalties for the game. It's speculated that this is due to the title not yet breaking even for publisher Square Enix.
While the reception for Biomutant itself wasn't overly positive, it is great to see a new IP find an audience. It may not have necessarily worked for us when we reviewed the game, but it's clear it has for others, and hopefully will mean we get a bigger and better sequel in the long run.
Were you one of the million players who picked up a copy of Biomutant? Let us know in the comments below.